Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetes.

Yu G, Tam CHT, Lim CKP, Shi M, Lau ESH, Ozaki R, Lee HM, Ng ACW, Hou Y, Fan B, Huang C, Wu H, Yang A, Cheung HM, Lee KF, Siu SC, Hui G, Tsang CC, Lau KP, Leung JYY, Cheung EYN, Tsang MW, Kam G, Lau IT, Li JKY, Yeung VTF, Lau E, Lo S, Fung S, Cheng YL, Szeto CC, Hong Kong Diabetes Biobank Study Group, Chow E, Kong APS, Tam WH, Luk AOY, Weedon MN, So WY, Chan JCN, Oram RA, Ma RCW, TRANSCEND Consortium.

Open source

DOI
10.1007/s00125-024-06309-y
Published
2024-11-12
Container
Diabetologia
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00125-024-06309-y,
  title = {Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetes.},
  author = {Yu G and  Tam CHT and  Lim CKP and  Shi M and  Lau ESH and  Ozaki R and  Lee HM and  Ng ACW and  Hou Y and  Fan B and  Huang C and  Wu H and  Yang A and  Cheung HM and  Lee KF and  Siu SC and  Hui G and  Tsang CC and  Lau KP and  Leung JYY and  Cheung EYN and  Tsang MW and  Kam G and  Lau IT and  Li JKY and  Yeung VTF and  Lau E and  Lo S and  Fung S and  Cheng YL and  Szeto CC and  Hong Kong Diabetes Biobank Study Group and  Chow E and  Kong APS and  Tam WH and  Luk AOY and  Weedon MN and  So WY and  Chan JCN and  Oram RA and  Ma RCW and  TRANSCEND Consortium.},
  year = {2025},
  journal = {Diabetologia},
  doi = {10.1007/s00125-024-06309-y},
  url = {https://doi.org/10.1007/s00125-024-06309-y}
}

RIS

TY  - JOUR
TI  - Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetes.
AU  - Yu G
AU  -  Tam CHT
AU  -  Lim CKP
AU  -  Shi M
AU  -  Lau ESH
AU  -  Ozaki R
AU  -  Lee HM
AU  -  Ng ACW
AU  -  Hou Y
AU  -  Fan B
AU  -  Huang C
AU  -  Wu H
AU  -  Yang A
AU  -  Cheung HM
AU  -  Lee KF
AU  -  Siu SC
AU  -  Hui G
AU  -  Tsang CC
AU  -  Lau KP
AU  -  Leung JYY
AU  -  Cheung EYN
AU  -  Tsang MW
AU  -  Kam G
AU  -  Lau IT
AU  -  Li JKY
AU  -  Yeung VTF
AU  -  Lau E
AU  -  Lo S
AU  -  Fung S
AU  -  Cheng YL
AU  -  Szeto CC
AU  -  Hong Kong Diabetes Biobank Study Group
AU  -  Chow E
AU  -  Kong APS
AU  -  Tam WH
AU  -  Luk AOY
AU  -  Weedon MN
AU  -  So WY
AU  -  Chan JCN
AU  -  Oram RA
AU  -  Ma RCW
AU  -  TRANSCEND Consortium.
PY  - 2025
JO  - Diabetologia
DO  - 10.1007/s00125-024-06309-y
UR  - https://doi.org/10.1007/s00125-024-06309-y
ER  - 

APA

G, Y., CHT, T., CKP, L., M, S., ESH, L., R, O., HM, L., ACW, N., Y, H., B, F., C, H., H, W., A, Y., HM, C., KF, L., SC, S., G, H., CC, T., KP, L., JYY, L., EYN, C., MW, T., G, K., IT, L., JKY, L., VTF, Y., E, L., S, L., S, F., YL, C., CC, S., Group, H. K. D. B. S., E, C., APS, K., WH, T., AOY, L., MN, W., WY, S., JCN, C., RA, O., RCW, M., & Consortium., T. (2025). Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetes.. Diabetologia. https://doi.org/10.1007/s00125-024-06309-y

Source records